160 related articles for article (PubMed ID: 10220485)
21. Studies on the metabolism of a monoterpene ketone, R-(+)-pulegone--a hepatotoxin in rat: isolation and characterization of new metabolites.
Madyastha KM; Raj CP
Xenobiotica; 1993 May; 23(5):509-18. PubMed ID: 8342298
[TBL] [Abstract][Full Text] [Related]
22. Biotransformations of R-(+)-pulegone and menthofuran in vitro: chemical basis for toxicity.
Madyastha KM; Raj CP
Biochem Biophys Res Commun; 1990 Dec; 173(3):1086-92. PubMed ID: 2268314
[TBL] [Abstract][Full Text] [Related]
23. Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes.
Wynalda MA; Hauer MJ; Wienkers LC
Drug Metab Dispos; 2000 Sep; 28(9):1014-7. PubMed ID: 10950842
[TBL] [Abstract][Full Text] [Related]
24. Biosynthesis of menthofuran in Mentha x piperita: stereoselective and mechanistic studies.
Fuchs S; Zinn S; Beck T; Mosandl A
J Agric Food Chem; 1999 Oct; 47(10):4100-5. PubMed ID: 10552773
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of (R)-(+)-pulegone in F344 rats.
Chen LJ; Lebetkin EH; Burka LT
Drug Metab Dispos; 2001 Dec; 29(12):1567-77. PubMed ID: 11717176
[TBL] [Abstract][Full Text] [Related]
26. 14C-labeled pulegone and metabolites binding to alpha2u-globulin in kidneys of male F-344 rats.
Ferguson LJ; Lebetkin EH; Lih FB; Tomer KB; Parkinson HD; Borghoff SJ; Burka LT
J Toxicol Environ Health A; 2007 Sep; 70(17):1416-23. PubMed ID: 17687727
[TBL] [Abstract][Full Text] [Related]
27. Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems.
Fontaine SM; Mash EA; Hoyer PB; Sipes IG
Drug Metab Dispos; 2001 Feb; 29(2):179-84. PubMed ID: 11159809
[TBL] [Abstract][Full Text] [Related]
28. In vivo studies on the metabolism of the monoterpene pulegone in humans using the metabolism of ingestion-correlated amounts (MICA) approach: explanation for the toxicity differences between (S)-(-)- and (R)-(+)-pulegone.
Engel W
J Agric Food Chem; 2003 Oct; 51(22):6589-97. PubMed ID: 14558782
[TBL] [Abstract][Full Text] [Related]
29. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
[TBL] [Abstract][Full Text] [Related]
30. Determination of cytochrome P450 enzymes involved in the metabolism of (-)-terpinen-4-ol by human liver microsomes.
Miyazawa M; Haigou R
Xenobiotica; 2011 Dec; 41(12):1056-62. PubMed ID: 22054099
[TBL] [Abstract][Full Text] [Related]
31. Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats.
Vadiraja BB; Gaikwad NW; Madyastha KM
Biochem Biophys Res Commun; 1998 Aug; 249(2):428-31. PubMed ID: 9712713
[TBL] [Abstract][Full Text] [Related]
32. Effects of drug metabolism modifiers on pulegone-induced hepatotoxicity in mice.
Mizutani T; Nomura H; Nakanishi K; Fujita S
Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):75-83. PubMed ID: 3432735
[TBL] [Abstract][Full Text] [Related]
33. Effect of ring size in R-(+)-pulegone-mediated hepatotoxicity: studies on the metabolism of R-(+)-4-methyl-2-(1-methylethylidene)-cyclopentanone and DL-camphorone in rats.
Thulasiram HV; Bhat VB; Madyastha MK
Drug Metab Dispos; 2001 Jun; 29(6):821-9. PubMed ID: 11353750
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of a monoterpene ketone, R-(+)-pulegone--a hepatotoxin in rat.
Moorthy B; Madyastha P; Madyastha KM
Xenobiotica; 1989 Feb; 19(2):217-24. PubMed ID: 2728495
[TBL] [Abstract][Full Text] [Related]
35. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver.
Mutch E; Williams FM
Toxicology; 2006 Jul; 224(1-2):22-32. PubMed ID: 16757081
[TBL] [Abstract][Full Text] [Related]
36. Tandem mass spectrometric analysis of S- and N-linked glutathione conjugates of pulegone and menthofuran and identification of P450 enzymes mediating their formation.
Lassila T; Mattila S; Turpeinen M; Pelkonen O; Tolonen A
Rapid Commun Mass Spectrom; 2016 Apr; 30(7):917-26. PubMed ID: 26969934
[TBL] [Abstract][Full Text] [Related]
37. Human hepatic cytochrome p450-specific metabolism of parathion and chlorpyrifos.
Foxenberg RJ; McGarrigle BP; Knaak JB; Kostyniak PJ; Olson JR
Drug Metab Dispos; 2007 Feb; 35(2):189-93. PubMed ID: 17079358
[TBL] [Abstract][Full Text] [Related]
38. Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice, and humans.
Kedderis GL; Held SD
Toxicol Appl Pharmacol; 1996 Sep; 140(1):124-30. PubMed ID: 8806878
[TBL] [Abstract][Full Text] [Related]
39. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
[TBL] [Abstract][Full Text] [Related]
40. Molecular response of Musca domestica L. to Mintostachys verticillata essential oil, (4R)+-pulegone and menthone.
Rossi YE; Canavoso L; Palacios SM
Fitoterapia; 2012 Mar; 83(2):336-42. PubMed ID: 22155595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
